Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Enhancement of KRAS protein stability by DX2 a DX2 levels in H460 lung ...
(a) Clonogenic assays showed that cell lines with KRAS mutation (H460 ...
A, KRAS mutant NSCLC cell lines (A549, NCI-H358 and NCI-H460) were ...
e Survivin knockdown and overexpression in mutant KRAS nonesmall cell ...
Methotrexate and pemetrexed decrease KRAS expression in KRAS-mutant ...
Anlotinib inhibits proliferation of KRAS mutant lung cancer cells. (A ...
| The inhibition of compound 0375-0604 on active KRAS. KRAS mutant ...
PDHK4 inhibits cell growth in mutant KRAS cells. (a) Schematic ...
e DR5 overexpression in both mutant KRAS and wild-type KRAS nonesmall ...
Silencing MUC1-C reverses EMT and KRAS independence. (A and B) Lysates ...
| Effect of honokiol on cell cycle progression KRAS mutant cell lines ...
| Flow cytometry analysis of honokiol induced apoptosis in KRAS mutant ...
| The effect of honokiol on KRAS signaling in KRAS mutant cell lines ...
| Honokiol induced autophagy though AMPK-mTOR dependent pathway in KRAS ...
| Blockade of autophagy reduced apoptosis of the honokiol-treated KRAS ...
Inhibition of HDAC6 synergizes with sorafenib to kill KRAS mutant ...
CREG1 is overexpressed in cell harboring KRAS mutations. (A) Total ...
KRAS Mutation Subtypes and Their Association with Other Driver ...
(PDF) Muc 1 confers EMT and KRAS independence in mutant KRAS lung ...
PTPN2 regulates the activation of KRAS and plays a critical role in ...
Differentiation of Kras Q61 mutants using digital droplet PCR. (A ...
Glycoproteomic Approach Identifies KRAS as a Positive Regulator of ...
Suppression of HDAC6 upregulated tubulin acetylation. A H460 and B A549 ...
MUC1-C promotes mutant KRAS NSCLC cell tumorigenicity. (A) A549/CshRNA ...
Mutant allele specific imbalance (MASI) for EGFR and KRAS genes. EGFR ...
The effect of HCPT and CRI on cell apoptosis of H460 (A), H1975 (B ...
MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer ...
Antitumor effects of APR-246 in both H460 and H460-Cis cells. (a–e ...
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
| Krukovine-induced cell cycle arrest in H460 and A549 cells. Three ...
Radiotherapy diagnostic biomarkers in radioresistant human H460 lung ...
Effects of OA treatment on stemness of H460 cells under... | Download ...
| Sirt3 protein expression was decreased in KRAS mutant cell lines and ...
Effects of KYA1797K on cell growth and proliferation of KRAS WT and MT ...
[보고서]MDM2 안타고니스트를 이용한 KRAS 돌연변이 폐암 세포의 ferroptosis 조절 기전 규명을 통한 치료 방법 연구
(A) Immunoblot of KRAS protein expression in H23, H1792, H358, H441 ...
The Role of KRAS Mutations in Colorectal Cancer: Biological Insights ...
KRAS G12C抑制剂的临床前评估-模型相关-澎立生物
Multiple Strategies to Develop Small Molecular KRAS Directly Bound ...
CRISPR/Cas9 Discovers KRAS Inhibitors in Cancer | Ubigene
The Future of KRAS Targeting Cancer Therapies Beyond G12C
Cells with inactivated LKB1 and activated KRAS are more sensitive to ...
Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC ...
Frontiers | Resistance to KRAS inhibition in advanced non-small cell ...
e Mutant KRAS sensitizes nonesmall cell lung cancer cells to treatment ...
Sensitisation of H460 and A549 cells to -radiation by TZT-1027 in vivo ...
Frontiers | The role of KRAS splice variants in cancer biology
IC50 values calculated from cell viability assays using KRAS mutant ...
Colorectal and lung wild-type KRAS cells are resistant to the ...
Difference Between Kras Mutation And Kras Wild Type at Alden Ortiz blog
HE and IHC in H460 tumor sections. (A) HE staining of H460 tumor ...
Viability and apoptosis were determined in the H460 cells treated with ...
(A) Feature importance summarized for H460 cellular and tissue data ...
Unconventional strategy could be the future: From target to KRAS broad ...
Mapping the KRAS Proteoform in Colorectal Cancer - MagLab
Representative images of H460 cells before (left) and 48 h after ...
Exploiting the therapeutic implications of KRAS inhibition on tumor ...
H460 cells (1*10 7 ) were inoculated subcutaneously in the right leg of ...
Frontiers | Current status of KRAS G12C inhibitors in NSCLC and the ...
Breaking the Undruggable Barrier: Targeted Inhibition of KRAS mutations ...
RAS-binding Affimers show different mutant specificities. a Panc 10.05 ...
Silencing of GSK3α/β induces apoptosis only in mutant (Mt ...
Synergy between CK2 and MEK inhibitors was observed in KRAS-active ...
The MAPK/ERK signaling axis contributes to BCL6 expression. (A and B ...
Focal Adhesion Kinase Regulates the DNA Damage Response and Its ...
| Colony formation of KRAS-mutated cells treated with krukovine (0, 5 ...
mTOR mediates chemotherapy resistance in KRAS-mutant lung cancer cells ...
Full article: Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung ...
Combined ZSTK474 and erlotinib can synergistically reduce proliferation ...
The result of established method was validated in cell lines Cell line ...
Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell ...
KRAS突变激活CD47实现肿瘤免疫逃逸，CD47抗体能否逆袭 - 知乎
KSR1 KO inhibits tumor initiating cell (TIC) survival and enhances ...
Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo ...
人类最常见的致癌基因之一——KRAS - 知乎
肠癌KRAS基因突变 - 知乎
SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant ...
LKB1 mutant tumor double strand break repair a, HR and NHEJ levels in ...
NCI-H460 Cells
AGO2 Is Essential for Mutant KRAS-Dependent Cell Proliferation (A ...
YY1/ZNF322A/Shh axis regulated angiogenesis in vitro and in vivo. A and ...
以核苷酸为作用对象的方法在诊断和治疗KRAS基因突变相关疾病中的应用与流程
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in ...
Chemotherapy-resistant KRAS-mutant lung cancer cells are not enriched ...
The migration of H460-RR was enhanced. (A) wound healing assay to ...
NSCLC. A, antitumor activity of abemaciclib in 4 KRAS-mutant (NCI-H358 ...
TAK1 inhibition by natural cyclopeptide RA-V promotes apoptosis and ...
CPTIA transactivation confers MEKi resistance. (A) Heat map ...
CAMSAP3 negatively regulates ERK activity. (A) Western blotting for ...
PIK3CAH1047R accelerates and enhances KRASG12D-driven lung ...
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity ...
The MEK inhibitor trametinib is a selective radiation sensitizer in ...
NCI-H460 cell line | Ubigene
Клетки NCI-H460
Shows the protein expression of Cytochrome-c (Cyt-c) in NSCLC cell ...
Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers ...
Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation ...
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine ...
KRASdependent suppression of MYC enhances the sensitivity of cancer ...
打破KRAS靶点“不可成药”的王牌药物「AMG 510」之诞生历程|KRAS|化合物|抑制剂|药物|蛋白|肿瘤|-健康界
Biomass-Haze PM2.5 from Northern Thailand Drives Genotype-Specific ...
【干货】KRAS突变治疗总结 - 知乎
What should we know about the 'undruggable' target KRAS? | MedChemExpress
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti ...
Alterations observed in NCI-H460 cellular metabolism after treatment ...
.jpg)
.jpg)
